Menopause and HRT Consultation in Patong, Phuket: Symptom Relief, Hormone Therapy and Long-Term Health
Modern, individualised menopause and hormone replacement therapy care for expat and visiting women in Patong, Kalim and Karon. Transdermal HRT, vaginal estrogen, non-hormonal options and long-term bone, heart and breast follow-up. Clinically reviewed by the Doctor Patong Takecare Clinic medical team.
WhatsApp now, seen within 30 minutes | Call +66 81 718 9080 | Find the clinic on Google Maps
Menopause care is one of the steadiest reasons women see our team in Patong. A large share of our patients are British, Australian, European or American women who have moved to Phuket in their late forties and fifties, and who need their HRT continued, reviewed or restarted after a gap. Others arrive in perimenopause, often blaming their symptoms on the heat, jet lag or work stress, and are surprised to find that hormone changes explain most of what they feel. The clinic-team approach is the same in every case: confirm where you are in the menopause transition, choose the safest effective treatment for your symptoms and risk profile, and put a long-term plan in place for bones, heart and breast screening.
Recognising menopause and perimenopause symptoms
Perimenopause begins four to eight years before the final period, usually in the mid-forties, and is marked by irregular cycles together with new symptoms. Around seventy to eighty percent of women experience vasomotor symptoms (hot flushes and night sweats), and these are typically the most disruptive. Genitourinary syndrome of menopause (GSM) covers vaginal dryness, painful sex, urinary urgency, recurrent urinary infections and vaginal itch, and tends to worsen rather than improve over time. Sleep disruption, anxiety, low mood, irritability, word-finding difficulty (brain fog), joint pains sometimes called menopause arthritis, central weight gain, reduced libido, hair thinning, skin dryness and worsening migraines are all common. Premature ovarian insufficiency, defined as menopause before forty, and surgical menopause after removal of both ovaries both need earlier investigation and stronger consideration of HRT for long-term bone and cardiovascular protection.
How we diagnose menopause
For most women over 45, menopause is a clinical diagnosis based on age, symptom pattern and menstrual history. Routine blood tests for follicle-stimulating hormone (FSH) are not needed and can be misleading because levels fluctuate in perimenopause. We only check FSH when menopause is suspected under 45, when symptoms are atypical, or when there is uncertainty after hysterectomy. Any unexpected vaginal bleeding after twelve months of no periods needs investigation before HRT is started, and a pregnancy test is appropriate for irregular bleeding in perimenopause. During the first visit our team takes a full personal and family history covering breast cancer, blood clots, stroke, migraine with aura, liver disease and cardiovascular risk, because this shapes the safest HRT route.
Hormone replacement therapy options
HRT is the single most effective treatment for vasomotor symptoms and GSM. Women with a uterus need estrogen plus a progestogen to protect the lining of the womb from over-stimulation; women who have had a hysterectomy can take estrogen alone. Modern guidance favours body-identical hormones: 17-beta estradiol delivered through the skin, combined with micronised progesterone taken at night. Transdermal routes (patch, gel or spray) avoid the first liver pass and carry essentially no excess risk of venous clot or stroke, which makes them the preferred starting point for new users and for anyone with higher baseline risk. Sequential HRT (cyclical bleed) suits perimenopausal women who are still having periods; continuous combined HRT (no bleed) suits postmenopausal women. The aim is the lowest effective dose, reviewed yearly.
HRT and non-hormonal options compared
| Option | Pros | Cons | Best suited to |
|---|---|---|---|
| Transdermal estradiol (patch, gel, spray) plus oral micronised progesterone | Most effective for hot flushes and night sweats. No excess clot or stroke risk. Steady blood levels. Easy to adjust dose. | Skin irritation in a small minority. Daily or twice-weekly application. | Most new starters, women over 50, smokers, high BMI, migraine with aura, family clot history. |
| Oral estradiol plus progestogen | Convenient daily tablet. Familiar to many long-term users. | Higher risk of venous clot than transdermal. Small increase in stroke risk. Avoid in liver disease and gallbladder disease. | Women already stable on oral HRT with low cardiovascular risk who prefer tablets. |
| Vaginal estrogen (pessary, ring, cream) | First-line for vaginal dryness, painful sex and recurrent urinary infections. Minimal systemic absorption. Safe long-term. | Does not treat hot flushes. Needs ongoing use to maintain benefit. | Any woman with GSM, including many who cannot take systemic HRT after breast cancer (with oncology agreement). |
| Non-hormonal (low-dose paroxetine, venlafaxine, gabapentin, fezolinetant, CBT) | Useful when HRT is contraindicated or declined. Fezolinetant targets the brain pathway behind hot flushes directly. | Generally less effective than HRT. Each option has its own side-effect profile. Does not protect bones. | After breast cancer, active venous clot, severe liver disease, or personal preference. |
Non-hormonal treatments for hot flushes
When HRT is not suitable or not wanted, evidence-based options exist. Low-dose paroxetine 7.5 mg is the only SSRI with a specific FDA approval for vasomotor symptoms, and venlafaxine 75 mg has the strongest trial data among SNRIs. Gabapentin works particularly well for night sweats, while clonidine remains a modest option. Fezolinetant (Veozah), a neurokinin-3 receptor antagonist, is the first non-hormonal medicine designed specifically for menopausal hot flushes and is a useful step forward for women who cannot take estrogen. Cognitive behavioural therapy delivered for menopause has good evidence for reducing how much hot flushes interfere with daily life, even when frequency itself does not change much.
Genitourinary symptoms and vaginal estrogen
GSM is under-treated because women rarely raise it spontaneously. Low-dose vaginal estrogen as a pessary, ring or cream is the first-line treatment and is one of the safest prescriptions in menopause care. Systemic absorption is negligible, the endometrium is not stimulated, and unlike systemic HRT it can usually be continued indefinitely and used alongside systemic HRT for women whose vaginal symptoms persist on patches alone. For women who prefer non-hormonal care, regular vaginal moisturisers used two or three times a week, plus a lubricant during sex, can give meaningful relief. Vaginal DHEA (prasterone) and oral ospemifene are useful second-line options. Recurrent urinary infections after menopause often resolve once vaginal estrogen restores the local tissue and is worth pairing with our Pap smear appointment if you are due.
Lifestyle, bone health and long-term review
Lifestyle measures support HRT rather than replace it. A five to ten percent reduction in body weight measurably reduces hot flush frequency. Combined aerobic and resistance exercise helps vasomotor symptoms, mood, sleep and bone density. Cutting alcohol and caffeine, dressing in layers, and keeping the bedroom cool reduces night sweats. Calcium intake of 1000 to 1200 mg per day and vitamin D 800 to 1000 IU per day support bone health in Phuket where sun exposure is paradoxically often low because expat women avoid the midday heat. Smoking cessation is non-negotiable: smoking worsens hot flushes, accelerates bone loss and amplifies cardiovascular risk. A DEXA bone-density scan is recommended at 65, earlier with risk factors such as low BMI, fracture history, family history of osteoporosis or long-term steroid use. If osteoporosis is confirmed, bisphosphonates (alendronate, risedronate) or denosumab are first-line. Postmenopausal cardiovascular risk rises sharply, so we screen and treat blood pressure and lipids alongside HRT, in coordination with our hypertension and cholesterol check services, and our annual health check-up covers breast awareness, mammography scheduling, BP, BMI and lipids in one visit.
When to see a doctor
The reason to book a menopause consultation is not severity alone. Many women tolerate symptoms because they assume nothing can be done, or because they have read alarming headlines about HRT that no longer reflect the evidence. A structured assessment lets you see the full picture: which symptoms are hormonal, which are not, what your individual risk profile looks like, and which treatment route fits your life in Phuket.
Any vaginal bleeding more than twelve months after your last period, or new heavy or irregular bleeding on HRT, needs investigation before treatment continues, to exclude endometrial pathology. A new breast lump, nipple discharge or skin change. A personal history of breast cancer, endometrial cancer, recent venous clot or stroke, active liver disease, recent heart attack, or undiagnosed pelvic mass. Sudden severe leg pain or swelling, chest pain or breathlessness while on HRT could indicate a clot and needs same-day assessment.
Hot flushes, sleep loss or mood changes are affecting your work, relationships or daily life. You are running low on HRT brought from your home country. You want a second opinion on whether HRT is right for you, or a review of an existing prescription. You are unsure whether what you feel is menopause, thyroid disease, depression or something else. WhatsApp +66 95 073 5550 for a same-day appointment or telephone advice.
Prevention and long-term protection
Menopause is not only a symptom problem; it is a long-term health pivot. After the final period, bone loss accelerates and cardiovascular risk catches up with men over the next decade. Starting HRT within ten years of menopause and before age 60 (the timing hypothesis) gives the best benefit-to-risk ratio and preserves bone density. Whether or not you take HRT, the prevention plan is consistent: weight-bearing and resistance exercise three or more times weekly, adequate calcium and vitamin D, blood pressure and lipids reviewed yearly, mammography on the schedule recommended in your home country, and cervical screening until 65.
Summary
Menopause symptoms are treatable, HRT is safer than its reputation when prescribed in modern transdermal form within the right window, and vaginal estrogen is one of the most useful and under-used prescriptions in women’s health. Our clinic team in Patong handles new diagnoses, ongoing HRT refills and brand changes, non-hormonal alternatives, and the wider follow-up of bones, heart and breast that menopause makes important. We are happy to coordinate with your home GP, write letters for travel insurance, and provide three or six monthly prescriptions to match your stay in Phuket.
“The most common thing we change at a first menopause visit is the route. Switching a woman from an oral combined pill to a transdermal patch with micronised progesterone often reduces her clot risk back to baseline and lets her keep the symptom relief she was worried about losing.”
Doctor Patong Takecare Clinic medical team
Frequently asked questions
Does HRT cause breast cancer?
The honest answer is a small increase in risk with combined estrogen plus progestogen HRT used for more than five years, and a smaller or no increase with estrogen-only HRT in women without a uterus. To give scale: the baseline breast cancer risk in women aged 50 to 59 is roughly 23 per 1000 over five years, and combined HRT for five years adds approximately 4 to 8 cases per 1000. Lifestyle factors such as alcohol intake and obesity carry a similar or greater risk. We discuss your individual numbers at the first visit so the decision is informed rather than abstract.
Are bioidentical hormones better than standard HRT?
Regulated body-identical hormones (17-beta estradiol patches or gels with micronised progesterone) are the modern first-line and are what most menopause societies now recommend. Compounded bioidentical hormones sold by private clinics with custom blends and saliva-test dosing are different: they are not regulated, doses are inconsistent, and they have no extra safety evidence over standard prescriptions. We prescribe regulated body-identical HRT and avoid compounded products.
Is vaginal estrogen safe to use long-term?
Yes. Low-dose vaginal estrogen produces minimal systemic absorption, does not stimulate the womb lining and does not carry the same risks as systemic HRT. It can usually be continued indefinitely. Many women with a history of breast cancer can use vaginal estrogen after discussion with their oncologist, because untreated GSM has a real impact on quality of life and sexual function.
Why is transdermal HRT preferred over oral tablets?
Estradiol absorbed through the skin bypasses the liver, which keeps clotting factors at baseline. The result is essentially no excess risk of venous clot or stroke with transdermal preparations, compared with a small but real increase with oral estrogen. For new starters, women over 50, smokers, higher BMI patients, migraine with aura sufferers and anyone with a family clot history, transdermal is the safer route.
Is it ever too late to start HRT?
Starting HRT before age 60 or within ten years of the final period gives the best balance of symptom relief and long-term cardiovascular and bone protection (the timing hypothesis). Outside that window, HRT is still possible for stubborn vasomotor symptoms but the cardiovascular risk-benefit is less favourable and the decision is more individual. Vaginal estrogen for GSM has no upper age limit.
Can you refill the HRT I brought from home?
In most cases, yes. We can continue your existing brand if it is available in Thailand, or switch you to the closest equivalent if it is not, with a clear explanation of any dose changes. Bring your current prescription or a photo of the box. We can also issue letters and three or six monthly supplies for longer stays, and liaise with your home GP if needed.
Sources
National Institute for Health and Care Excellence. Menopause: identification and management, NG23. nice.org.uk/guidance/ng23.
British Menopause Society. Tools for clinicians and HRT prescribing guide. thebms.org.uk.
The Menopause Society (formerly NAMS). 2022 Hormone Therapy Position Statement. menopause.org/professional-resources/position-statements.
Book a menopause and HRT consultation
WhatsApp: same-day appointment
Call +66 81 718 9080 to speak to our team
Find Doctor Patong Takecare Clinic on Google Maps
Menopause, perimenopause, postmenopause, premature ovarian insufficiency, surgical menopause, vasomotor symptoms, hot flushes, night sweats, genitourinary syndrome of menopause, GSM, vaginal dryness, dyspareunia, hormone replacement therapy, HRT, MHT, estradiol, 17-beta estradiol, micronised progesterone, transdermal estrogen, estrogen patch, estrogen gel, vaginal estrogen, pessary, ospemifene, prasterone, DHEA, paroxetine, venlafaxine, gabapentin, fezolinetant, Veozah, CBT, osteoporosis, DEXA scan, bisphosphonate, alendronate, denosumab, cardiovascular risk, breast cancer screening, mammography, FSH, NICE NG23, British Menopause Society, The Menopause Society, NAMS, IMS, RCOG, Patong, Kalim, Karon, Phuket, expat women’s health, Doctor Patong Takecare Clinic.